Utkarsh Goel

19PUBLICATIONS
76CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersMolecular targetsTe urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 16, 2026
Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma.

|Apr 29, 2026
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.

|Apr 23, 2026
Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

|Nov 12, 2025
The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis.

Matthew J Rees, Jack Khouri, Ariel F Grajales-Cruz

Pageof 4

Frequent Collaborators

11 joint publications

Faiz Anwer

10 joint publications

Jack Khouri

7 joint publications

Shahzad Raza

6 joint publications

Shaji Kumar